Anzeige
Mehr »
Freitag, 20.03.2026 - Börsentäglich über 12.000 News
Während Kupfer zum Engpass wird, startet diese Aktie in Nevada die nächste große Explorationsphase
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PAJG | ISIN: CNE100003F19 | Ticker-Symbol: WX8
Tradegate
19.03.26 | 20:07
11,900 Euro
0,00 % 0,000
1-Jahres-Chart
WUXI APPTEC CO LTD Chart 1 Jahr
5-Tage-Chart
WUXI APPTEC CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
11,80011,90019.03.
11,70012,00019.03.

Aktuelle News zur WUXI APPTEC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.03.WUXI APPTEC (02359): DATE OF BOARD MEETING3
WUXI APPTEC Aktie jetzt für 0€ handeln
27.02.CLSA Favors CDMOs for Earnings Visibility, Top Picks WUXI APPTEC/WUXI BIO/PHARMARON31
20.02.M Stanley Hikes TP of WUXI APPTEC to HKD143.5, Rating Overweight4
13.01.WuXi AppTec Jumps After Chinese Drugmaker Raises 2025 Earnings Forecast Again8
12.01.WuXi AppTec Issues Positive Profit Alert for the Full Year of 2025373SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and...
► Artikel lesen
12.01.WUXI APPTEC (02359): POSITIVE PROFIT ALERT2
07.01.WUXI APPTEC (02359): FURTHER GRANT OF AWARDS UNDER THE 2024 H SHARE AWARD AND TRUST SCHEME1
15.12.25WUXI APPTEC (02359): BUSINESS UPDATE IN CONNECTION WITH COMPLETION OF DISPOSAL OF SUBSIDIARIES4
04.12.25After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg21
20.11.25WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry646WuXi AppTec sets new benchmarks in strategic execution and technological advancement, further strengthening its ability to support innovators worldwide as they deliver breakthrough medicines...
► Artikel lesen
19.11.25China's corporate pivots: Alibaba's food delivery gambit and WuXi AppTec's geopolitical hedge11
06.11.25WuXi AppTec Steps Up Middle East Push By Offloading Non-Core Chinese Assets3
06.11.25WuXi AppTec frees up money for Middle East push7
28.10.25WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health557SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced it has...
► Artikel lesen
27.10.25WuXi AppTec GAAP EPS of RMB1.22, revenue of RMB12.06B3
27.10.25China's WuXi AppTec Jumps After Drugmaker Raises 2025 Earnings Forecast as Third-Quarter Profit Surges6
27.10.25WuXi AppTec Q3 2025 slides: Revenue jumps 22.5%, raises full-year guidance3
26.10.25WuXi AppTec Q3 Profit Rises; Lifts FY Outlook3
26.10.25WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance333Q3 Total Revenue: RMB12.06 Billion, Up 15.3% YoY; Revenue from Continuing Operations [1] Reached RMB12.04 Billion, Up 19.7% YoY Q1-Q3 Total Revenue:...
► Artikel lesen
10.10.25WUXI APPTEC (02359): FULL CONVERSION AND WITHDRAWAL OF LISTING OF THE U.S.$500,000,000 ZERO COUPON GUARANTEED CONVERTIBLE BONDS DUE 20252
Weiter >>
71 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1